Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 191

1.

Changing epidemiology of pediatric Staphylococcus aureus bacteremia in Denmark from 1971 through 2000.

Frederiksen MS, Espersen F, Frimodt-Møller N, Jensen AG, Larsen AR, Pallesen LV, Skov R, Westh H, Skinhøj P, Benfield T.

Pediatr Infect Dis J. 2007 May;26(5):398-405.

PMID:
17468649
2.

Increasing incidence but decreasing in-hospital mortality of adult Staphylococcus aureus bacteraemia between 1981 and 2000.

Benfield T, Espersen F, Frimodt-Møller N, Jensen AG, Larsen AR, Pallesen LV, Skov R, Westh H, Skinhøj P.

Clin Microbiol Infect. 2007 Mar;13(3):257-63.

3.

Hearing loss and cochlear damage in experimental pneumococcal meningitis, with special reference to the role of neutrophil granulocytes.

Brandt CT, Cayé-Thomasen P, Lund SP, Worsøe L, Ostergaard C, Frimodt-Møller N, Espersen F, Thomsen J, Lundgren JD.

Neurobiol Dis. 2006 Aug;23(2):300-11. Epub 2006 Jun 22.

PMID:
16798006
4.

Blocking of leukocyte accumulation in the cerebrospinal fluid augments bacteremia and increases lethality in experimental pneumococcal meningitis.

Brandt CT, Lundgren JD, Frimodt-Møller N, Christensen T, Benfield T, Espersen F, Hougaard DM, Ostergaard C.

J Neuroimmunol. 2005 Sep;166(1-2):126-31.

PMID:
15982752
5.

Susceptibility testing of urinary isolates of Escherichia coli to mecillinam using NCCLS methodology.

Skov R, Frimodt-Moller N, Menday P, Espersen F.

Int J Antimicrob Agents. 2005 Mar;25(3):198-204. Epub 2005 Jan 5.

PMID:
15737512
6.

Attenuation of the bacterial load in blood by pretreatment with granulocyte-colony-stimulating factor protects rats from fatal outcome and brain damage during Streptococcus pneumoniae meningitis.

Brandt CT, Lundgren JD, Lund SP, Frimodt-Møller N, Christensen T, Benfield T, Espersen F, Hougaard DM, Østergaard C.

Infect Immun. 2004 Aug;72(8):4647-53.

7.

Simple, rapid latex agglutination test for serotyping of pneumococci (Pneumotest-Latex).

Slotved HC, Kaltoft M, Skovsted IC, Kerrn MB, Espersen F.

J Clin Microbiol. 2004 Jun;42(6):2518-22.

8.

Urinary concentrations and urine ex-vivo effect of mecillinam and sulphamethizole.

Kerrn MB, Frimodt-Møller N, Espersen F.

Clin Microbiol Infect. 2004 Jan;10(1):54-61.

9.

Tentative interpretative zone diameters for fusidic acid Neosensitabs on Mueller Hinton agar and three blood containing media.

Skov R, Frimodt-Møller N, Espersen F.

Int J Antimicrob Agents. 2003 Nov;22(5):502-7.

PMID:
14602369
10.
11.

Selection of resistant Streptococcus pneumoniae during penicillin treatment in vitro and in three animal models.

Knudsen JD, Odenholt I, Erlendsdottir H, Gottfredsson M, Cars O, Frimodt-Møller N, Espersen F, Kristinsson KG, Gudmundsson S.

Antimicrob Agents Chemother. 2003 Aug;47(8):2499-506.

12.

Evaluation of fusidic acid in therapy of experimental Staphylococcus aureus meningitis.

Østergaard C, Yieng-Kow RV, Knudsen JD, Frimodt-Møller N, Espersen F.

J Antimicrob Chemother. 2003 May;51(5):1301-5. Epub 2003 Apr 14.

PMID:
12697637
13.
14.
15.

[The National Serum Institute 1902-2002].

Pedersen NS, Espersen F, Axelsen N.

Ugeskr Laeger. 2002 Sep 9;164(37):4261-5. Danish. No abstract available.

PMID:
12362865
16.

[Staphylococcus aureus infections--the clinical picture and treatment].

Gahrn-Hansen B, Espersen F, Frimodt-Møller N, Riegels-Nielsen P, Pedersen SS.

Ugeskr Laeger. 2002 Aug 5;164(32):3759-63. Review. Danish.

PMID:
12362608
17.
18.

Validation of FLEXICULT SSI-Urinary Kit for use in the primary health care setting.

Blom M, Sørensen TL, Espersen F, Frimodt-Møller N.

Scand J Infect Dis. 2002;34(6):430-5.

PMID:
12160170
19.

Treatment and outcome of Staphylococcus aureus bacteremia: a prospective study of 278 cases.

Jensen AG, Wachmann CH, Espersen F, Scheibel J, Skinhøj P, Frimodt-Møller N.

Arch Intern Med. 2002 Jan 14;162(1):25-32.

PMID:
11784216
20.

Evaluation of seven different enzyme-linked immunosorbent assays for serodiagnosis of Staphylococcus aureus bacteremia.

Ryding U, Espersen F, Söderquist B, Christensson B.

Diagn Microbiol Infect Dis. 2002 Jan;42(1):9-15.

PMID:
11821165
21.

In vitro antimicrobial susceptibility of Aerococcus urinae to 14 antibiotics, and time-kill curves for penicillin, gentamicin and vancomycin.

Skov R, Christensen JJ, Korner B, Frimodt-Møller N, Espersen F.

J Antimicrob Chemother. 2001 Nov;48(5):653-8.

PMID:
11679554
22.

Transient intestinal carriage after ingestion of antibiotic-resistant Enterococcus faecium from chicken and pork.

Sørensen TL, Blom M, Monnet DL, Frimodt-Møller N, Poulsen RL, Espersen F.

N Engl J Med. 2001 Oct 18;345(16):1161-6.

23.

Control of resistance to sulphonamides.

Kerrn MB, Klemmensen T, Espersen F, Frimodt-Møller N.

Lancet. 2001 Sep 1;358(9283):761-2. No abstract available.

PMID:
11556347
24.
25.

Penicillin pharmacodynamics in four experimental pneumococcal infection models.

Erlendsdottir H, Knudsen JD, Odenholt I, Cars O, Espersen F, Frimodt-Møller N, Fuursted K, Kristinsson KG, Gudmundsson S.

Antimicrob Agents Chemother. 2001 Apr;45(4):1078-85.

26.
27.

Treatment with a monocolonal antibody to IL-8 attenuates the pleocytosis in experimental pneumococcal meningitis in rabbits when given intravenously, but not intracisternally.

Ostergaard C, Yieng-Kow RV, Larsen CG, Mukaida N, Matsushima K, Benfield T, Frimodt-Møller N, Espersen F, Kharazmi A, Lundgren JD.

Clin Exp Immunol. 2000 Nov;122(2):207-11.

29.

Pharmacodynamics of glycopeptides in the mouse peritonitis model of Streptococcus pneumoniae or Staphylococcus aureus infection.

Knudsen JD, Fuursted K, Raber S, Espersen F, Frimodt-Moller N.

Antimicrob Agents Chemother. 2000 May;44(5):1247-54.

30.

[Staphylococcus aureus endocarditis in Denmark 1982-1991. Clinical picture, complications and antibiotic therapy in non-drug addicts].

Røder BL, Wandall DA, Frimodt-Møller N, Espersen F, Skinhøj P, Rosdahl VT.

Ugeskr Laeger. 2000 Jan 17;162(3):345-9. Danish.

PMID:
10680471
32.

Risk factors for hospital-acquired Staphylococcus aureus bacteremia.

Jensen AG, Wachmann CH, Poulsen KB, Espersen F, Scheibel J, Skinhøj P, Frimodt-Møller N.

Arch Intern Med. 1999 Jul 12;159(13):1437-44.

PMID:
10399895
33.
34.

Evaluation of Statens Serum Institut enteric medium for detection of enteric pathogens.

Blom M, Meyer A, Gerner-Smidt P, Gaarslev K, Espersen F.

J Clin Microbiol. 1999 Jul;37(7):2312-6.

36.

Detection of clinical vancomycin-resistant enterococci in Denmark by multiplex PCR and sandwich hybridization.

Poulsen RL, Pallesen LV, Frimodt-Møller N, Espersen F.

APMIS. 1999 Apr;107(4):404-12.

PMID:
10230695
37.

Clinical features of Staphylococcus aureus endocarditis: a 10-year experience in Denmark.

Røder BL, Wandall DA, Frimodt-Møller N, Espersen F, Skinhøj P, Rosdahl VT.

Arch Intern Med. 1999 Mar 8;159(5):462-9.

PMID:
10074954
38.

Resistance to antibiotics used in dermatological practice.

Espersen F.

Br J Dermatol. 1998 Dec;139 Suppl 53:4-8. Review.

PMID:
9990406
39.

Serological diagnosis of experimental Enterococcus faecalis endocarditis.

Kjerulf A, Espersen F, Gutschik E, Majcherczyk PA, Hougen HP, Rygaard J, Høiby N.

APMIS. 1998 Oct;106(10):997-1008.

PMID:
9833704
40.

Pharmacodynamics of penicillin are unaffected by bacterial growth phases of Streptococcus pneumoniae in the mouse peritonitis model.

Knudsen JD, Frimodt-Møller N, Espersen F.

J Antimicrob Chemother. 1998 Apr;41(4):451-9.

PMID:
9598776
41.

Comparison of pharmacodynamics of azithromycin and erythromycin in vitro and in vivo.

den Hollander JG, Knudsen JD, Mouton JW, Fuursted K, Frimodt-Møller N, Verbrugh HA, Espersen F.

Antimicrob Agents Chemother. 1998 Feb;42(2):377-82.

42.

Bacteremic Staphylococcus aureus spondylitis.

Jensen AG, Espersen F, Skinhøj P, Frimodt-Møller N.

Arch Intern Med. 1998 Mar 9;158(5):509-17.

PMID:
9508229
43.

Staphylococcus aureus bacteraemia among patients undergoing dialysis--focus on dialysis catheter-related cases.

Nielsen J, Kolmos HJ, Espersen F.

Nephrol Dial Transplant. 1998 Jan;13(1):139-45.

PMID:
9481730
44.
45.

Antimicrobial susceptibility testing of 230 Helicobacter pylori strains: importance of medium, inoculum, and incubation time.

Hartzen SH, Andersen LP, Bremmelgaard A, Colding H, Arpi M, Kristiansen J, Justesen T, Espersen F, Frimodt-Møller N, Bonnevie O.

Antimicrob Agents Chemother. 1997 Dec;41(12):2634-9.

46.

Problems with antibiotic resistance in Spain and their relation to antibiotic use in humans elsewhere.

Frimodt-Møller N, Espersen F, Jacobsen B, Schlundt J, Meyling A, Wegener H.

Clin Infect Dis. 1997 Oct;25(4):939-41. No abstract available.

PMID:
9356825
47.
48.

Evaluation of different methods for the detection of methicillin resistance in coagulase-negative staphylococci.

Jarløv JO, Busch-Sørensen C, Espersen F, Mortensen I, Hougaard DM, Rosdahl VT.

J Antimicrob Chemother. 1997 Aug;40(2):241-9. Erratum in: J Antimicrob Chemother 1998 Feb;41(2):317-8.

PMID:
9301990
49.

Epidemiology of Staphylococcus aureus bacteremia in Denmark from 1957 to 1990.

Frimodt-Møller N, Espersen F, Skinhøj P, Rosdahl VT.

Clin Microbiol Infect. 1997 Jun;3(3):297-305.

50.

Neurologic manifestations in Staphylococcus aureus endocarditis: a review of 260 bacteremic cases in nondrug addicts.

Røder BL, Wandall DA, Espersen F, Frimodt-Møller N, Skinhøj P, Rosdahl VT.

Am J Med. 1997 Apr;102(4):379-86.

PMID:
9217620

Supplemental Content

Loading ...
Support Center